摘要:
A biguanide derivative compound with N4-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPK and inhibition of cancer cell proliferation in a low dose, compared with conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.
摘要:
The present invention relates to a pharmaceutical composition for treating scars on the skin, comprising a mixture of botulinum toxin and air. The mixture of botulinum toxin and air according to the present invention, when injected in the dermis, may temporarily removed the elasticity of the dermis and flatten out the depressed part of the scar, and thus enables elaborate intradermic resection and increases the therapeutic effects of lasers for treating pulsed dye laser or of fractional lasers. Thus, scars on the skin can be effectively improved through a one-time operation without negatively affecting the daily lives of patients.
摘要:
An N1-cyclic amine-N5-substituted phenyl biguanide derivative of Formula 1 or a pharmaceutically acceptable salt thereof, a method of manufacturing the same, and a pharmaceutical composition including the biguanide derivative or the pharmaceutically acceptable salt thereof as an active ingredient are provided. The biguanide derivatives have an effect of inhibiting cancer cell proliferation and also exhibit anticancer activity including inhibition of cancer metastasis and cancer recurrence, because they are effective in activating AMPK, which is associated with the control of energy metabolism, even when administered in a small dose compared with conventional drugs. Also, the biguanide derivatives are highly effective at lowering blood glucose and lipid concentration by AMPK activation, thus they may be effectively used to treat diabetes mellitus, obesity, hyperlipemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovary syndrome and metabolic syndrome.
摘要:
The present invention relates to a pharmaceutical composition for treating scars on the skin, comprising a mixture of botulinum toxin and air. The mixture of botulinum toxin and air according to the present invention, when injected in the dermis, may temporarily removed the elasticity of the dermis and flatten out the depressed part of the scar, and thus enables elaborate intradermic resection and increases the therapeutic effects of lasers for treating pulsed dye laser or of fractional lasers. Thus, scars on the skin can be effectively improved through a one-time operation without negatively affecting the daily lives of patients.
摘要:
A printing control apparatus is provided. The printing control apparatus includes a user interface to set a printing option for a document to be printed, an extraction unit to determine whether the set printing option is a printing option for pre-processing, a generation unit to generate a setting file corresponding to the pre-processing printing option if the printing option is the pre-processing printing option, a conversion unit to convert an XPS file into an enhanced XPS file that includes the generated setting file, and a controller to transmit the enhanced XPS file to the image forming apparatus.
摘要:
A method of manufacturing a hydrophilic membrane and hydrophilic membranes having improved antifouling property using a supercritical fluid or a subcritical fluid. The method involves combining a coating solution from a hydrophilic group-containing monomer, an initiator, a cross-linking agent and a supercritical fluid or subcritical fluid in a high pressure solution vessel and transferring the coating solution to a membrane in a high pressure coating vessel, coating the surfaces and micropores of the membranes through cross-linking polymerization reactions. Non-reacted coating material is returned to the high pressure solution vessel. The membranes are removed from the coating vessel, cleaned and dried. The hydrophilic membrane manufactured by the present invention is excellent in properties of hydrophobic membranes such as thermal stability, chemical stability and mechanical strength, and surfaces and micropores of the membranes are uniformly coated.
摘要:
Disclosed are biaryl benzoimidazo derivatives. They have an inhibitory effect on calcium influx in HEK cells, thereby showing a powerful antagonistic effect on a vanilloid receptor, and further have an analgesic effect, thereby being useful for preventing or treating pain, acute pain, chronic pain, neuropathic pain, postoperative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurological illness, neurodermatitis, stroke, bladder hypersensitivity, irritable bowel syndrome, a respiratory disorder such as cough, asthma, and chronic obstructive pulmonary disease, burning, psoriasis, itching, vomiting, irritation of the skin, eyes, and mucous membranes, gastric-duodenal ulcers, inflammatory intestinal diseases, and inflammatory diseases.
摘要:
Disclosed are a method of producing metal nanoparticles continuously, and metal nanoparticles produced thereby. The method comprises: (a) preparing a metal precursor solution by dissolving a metal precursor in alcohol; (b) continuously putting the metal precursor solution into a reactor having supercritical conditions, thereby producing metal nanoparticles; (c) cooling the solution obtained in step (b); and (d) separating and collecting the metal nanoparticles from the solution obtained in step (c).
摘要:
A biguanide derivative compound with N1-N5 substitution, which is represented by Formula 1, or a pharmaceutically acceptable salt thereof, a method of preparing the same, and a pharmaceutical composition containing the same as an active ingredient are provided. The biguanide derivative may exhibit excellent effect on activation of AMPKα and inhibition of cancer cell proliferation in a low dose, compared to conventional drugs, and thus, may be useful to treat diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovarian syndrome, metabolic syndrome, cancer, etc.